Clinical Data Registry of Amblyopia Patients on Luminopia Treatment

Launched by LUMINOPIA · May 20, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how well Luminopia treatment works for patients with amblyopia, a condition that affects vision in one eye and is common in children and young adults. Amblyopia can make it hard to see clearly and can impact other visual skills like depth perception and reading ability. Since Luminopia became available in late 2022, more patients are starting this treatment, and this trial aims to collect information from those patients to better understand how it is being used in real-life settings.

To take part in this trial, you need to have been diagnosed with amblyopia and have been receiving Luminopia treatment for at least 12 weeks. Unfortunately, if you have already participated in other Luminopia clinical trials, you won't be eligible. Participants can expect to contribute to important research that may help improve amblyopia treatment in the future, and their experiences will help doctors learn more about how Luminopia works in everyday practice.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Have a diagnosis of amblyopia
• • Have undergone or currently undergoing Luminopia treatment for a minimum of 12 weeks
• Exclusion Criteria:
• • -Have participated in prior Luminopia clinical trials